HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of immuno-potent drugs and their association with an unfractionated heparin on an experimental venous thrombosis.

Abstract
Immuno-potent drugs are largely used in human medicine. The aim of this study was to determine the role of two immuno-modulators (sodium diethyl-dithiocarbamate, RU 41 740) and two immuno-suppressors (methylprednisolone, cyclosporin A) alone or in association with an unfractionated heparin (Calciparin), on an experimental venous thrombosis made by vena cava ligation in male Wistar rats. Each immuno-potent drug was administered for six days before the thrombus induction at the same dosage (10mg/kg b.w.), and the Calciparin, used as treatment of the thrombosis, was administered two hours after the thrombus induction at the dose of 1mg/kg b.w. Immuno-treatment potentiated thrombus formation: the increase in thrombus weight was greater with immuno-modulators (43% on average in comparison with placebo) than with immuno-suppressors (20%). In association with Calciparin the antithrombotic effect was also potentiated and more marked with the immuno-modulators than with immuno-suppressors. An increase in circulating monocytes was observed in all groups whether Calciparin was present or not. Coagulation tests were not affected by immuno-therapy. However, immuno-modulators led to an inhibition of platelet aggregation. In conclusion, this trial seems to show a probable effect of immunological cells in thrombosis and in the antithrombotic effect of heparin, but the mechanism involved is not yet determined.
AuthorsC Puyal, M C Lalanne, C Doutremepuich
JournalThrombosis research (Thromb Res) Vol. 64 Issue 2 Pg. 263-72 (Oct 15 1991) ISSN: 0049-3848 [Print] United States
PMID1811344 (Publication Type: Journal Article)
Chemical References
  • Adjuvants, Immunologic
  • Immunosuppressive Agents
  • Platelet Aggregation Inhibitors
  • Heparin
Topics
  • Adjuvants, Immunologic (therapeutic use)
  • Animals
  • Heparin (therapeutic use)
  • Immunosuppressive Agents (therapeutic use)
  • Leukocyte Count
  • Male
  • Platelet Aggregation
  • Platelet Aggregation Inhibitors (therapeutic use)
  • Rats
  • Rats, Inbred Strains
  • Thrombophlebitis (blood, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: